Novartis Vaccines And Diagnostics Company Profile

Aggregated data from the web about Novartis Vaccines And Diagnostics

Company Name	Novartis Vaccines And Diagnostics
Website	https://www.novartis.com
Snippet	Novartis is hosting the Co-Creating Impact Summit on December 9th, 2020, gathering experts inside and outside of the company to discuss some key ESG topics. Register. Novartis included in Dow Jones Sustainability Index. Novartis is proud to be included in one of the most important ESG ratings.
ISIN	CH0012005267
Type	Public (Aktiengesellschaft)
Founded	1996, (from merger)
Revenue	US$47.5 billion (2019)[2]
Website	Novartis.com
Founders	Johann RudolfAlexander Clavel
Industry	Pharmaceuticals
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Traded as	SIX: NOVN, NYSE: NVS
Key people	Vasant Narasimhan (CEO)[1]
Net income	US$11.73 billion (2019)[2]
Area served	Worldwide
Predecessor	Ciba-Geigy, Sandoz (via merger)
Headquarters	Basel, Switzerland
Total assets	US$118.37 billion (2019)[2]
Total equity	US$55.55 billion (2019)[2]
Operating income	US$9.08 billion (2019)[2]
Number of employees	103,914[2] (2019)

Novartis Vaccines And Diagnostics is part of the Switzerland company list

Novartis Vaccines And Diagnostics is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.